<DOC>
	<DOCNO>NCT00536679</DOCNO>
	<brief_summary>The study consist screening period , 3 treatment period post-treatment follow-up . In 3 treatment period , subject receive single oral dose GSK163090 feed fasted state , follow 7-day wash-out period dose</brief_summary>
	<brief_title>Relative Bioavailability Food Effect Study GSK163090 Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Healthy male female subject age 18 55 year inclusive . If female , subject eligible enter participate study lactate Nonchildbearing potential Childbearing potential , negative pregnancy test screen baseline agree adequate contraception : Body weight â‰¥ 50 kg body mass index ( BMI ) 18.5 29.9 kg/m2 inclusive . Capable give informed consent comply study requirement timetable . Selfadministered Beck Depression Inventory II scale total score great 9 , suicide question score zero . The subject must able read , comprehend record information . A signed date write informed consent obtain subject . Nonsmoker ( abstinence smoking least 6 month start study ) . Agrees abstain ingest caffeine xanthinecontaining product 24 hour prior start dose collection final pharmacokinetic sample . Agree abstain alcohol 24 hour prior start dose collection final pharmacokinetic sample As result medical interview , physical examination screen investigation physician responsible considers subject unfit study . The subject history drug allergy opinion physician responsible contraindicates participation study . The subject currently participate participate clinical trial new chemical entity previous 4 month trial previous 3 month . The subject screening ECG value outside protocoled range The subject pulse rate &lt; 45 &gt; 100 bpm systolic blood pressure &gt; 150 &lt; 90 diastolic blood pressure &gt; 90 &lt; 50 . History long QT syndrome ( personal family ) cardiac conduction disorder , clinically significant cardiac disease . The subject liver function test ( LFT ) elevate &gt; 1.5 time reference range prestudy screen remain elevated repeat LFT . Any clinically significant laboratory abnormality . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator sponsor medication interfere study procedure compromise subject safety . Abuse alcohol define average weekly intake great 21 unit male 14 unit female average daily intake great 3 unit male 2 unit female . 1 unit equivalent halfpint ( 220mL ) beer 1 ( 25ml ) measure spirit 1 glass ( 125ml ) wine . Consumption grapefruit juice grapefruit within 7 day prior first dose study medication collection last PK sample . The subject unable abstain strenuous physical activity 48 h prior screen follow 48 h prior 48 h treatment period . Where participation study would result donation blood excess 500 mL within 90 day period An unwillingness male subject abstain , use adequate contraception , sexual intercourse pregnant lactate woman time first dose study medication 90 day follow administration last dose study medication OR An unwillingness male subject use adequate contraception addition female partner use another form contraception woman could become pregnant time first dose study medication 90 day follow administration last dose study medication . Current recent ( within one year ) gastrointestinal disease ; history malabsorption , esophageal reflux , irritable bowel syndrome ; frequent ( week ) occurrence heartburn ; surgical intervention ( e.g. , cholecystectomy ) would expect influence absorption drug . The subject history psychiatric illness Any history suicidal attempt behavior . The subject test positive hepatitis C antibody hepatitis B surface antigen . The subject test positive HIV . The subject past history drug abuse test positive urine drug abuse prestudy screening . The subject history serotonin syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>GSK163090</keyword>
	<keyword>Relative Bioavailability</keyword>
	<keyword>Food Effect</keyword>
	<keyword>Randomised</keyword>
</DOC>